Could a smart dental filler stop white spots before they start?

NCT ID NCT07715942

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests whether a bioactive resin containing S-PRG filler, used as attachment material for clear orthodontic aligners, can prevent white spot lesions (early decay) on tooth enamel. Fifty healthy young adults with mild to moderate crowding will be randomly assigned to receive either the bioactive resin or a standard flowable composite for their aligner attachments. The study measures changes in lesion area and mineral loss using a quantitative light-induced fluorescence system.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bioactive resin composite containing S-PRG filler
What this could lead to
If it works, this could offer a way to prevent white spot lesions (early tooth decay) during orthodontic treatment with clear aligners.
What could go wrong
This is a small early-stage trial with 50 participants, so results may not apply broadly. The material may not significantly reduce lesions compared to standard composites.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jul 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy young adult orthodontic patients * Class 1 malocclusion with mild to moderate crowding (\<6 mm). * Non extraction treatment plan. * Optimum oral Hygiene before treatment. * A maximum of three restored teeth with either fillings or prosthesis. Exclusion Criteria: * Patients with defective enamel, fluorosis, hypocalcification or enamel hypoplasia. * Extensive restorations. * Syndromes and Oro-facial anomalies. * Salivary gland diseases. * Patients who are pregnant, diabetic, or using mouth rinses or interacting medications, including antibiotic therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for White spot lesion of tooth are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Postgraduate Orthodontic Clinics

    Irbid, 22110, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.